Elizabeth Hurst, APRN
Family · Louisville, KYNPI 1407224470
Payments from drug & device makers
Across 29 payments — averaging $19.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$237
- Novo Nordisk$50
- Novartis$39
- E.r. Squibb & Sons, L.L.C.$36
- Mallinckrodt Hospital Products Inc.$34
- AbbVie$29
- plus $130 from 7 others
What the payments were for
- Food & beverage$555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $237 |
| Novo Nordisk | 3 | $50 |
| Novartis | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| AbbVie | 2 | $29 |
| Amgen | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Avinger Inc. | 1 | $14 |
How this compares
$555 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $9,683 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $2,326 |
| Gabapentin | 65 | $1,007 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $912 |
| Torsemide | 17 | $743 |
| Potassium Chloride | 31 | $711 |
| Nystatin | 25 | $699 |
| Tramadol Hcl | 21 | $691 |
| Ondansetron OdtOndansetron | 20 | $552 |
| Pantoprazole Sodium | 32 | $552 |
| Tamsulosin Hcl | 15 | $446 |
| Furosemide | 49 | $380 |
| Fluticasone Propionate | 14 | $357 |
| Metoprolol Succinate | 18 | $350 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 13 | $336 |
Paid to pharmacies, not to this prescriber.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.